Rexahn Pharmaceuticals (RNN) Posts Breakeven Q2 Loss; Issues Pipeline Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. DVLT
8. ADYYF
9. WDAY
10. ADYEN:NA

Go back to Rexahn Pharmaceuticals (RNN) Posts Breakeven Q2 Loss; Issues Pipeline Update

Roth Affirms Rexahn (RNN) at 'Buy'; Comments on Q2 Results, Pipeline Update

August 14, 2014 9:45 AM EDT

Roth Capital maintains Rexahn Pharmaceuticals (AMEX: RNN) at Buy with a price target of $3 following the company's Q2 results and pipeline update.

Analyst Joseph Pantginis commented, The financial results currently do not impact our investment case. The... More